Journal Article

DKFZ-2021-02278

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Dimethyl fumarate (DMF) therapy in CTCL: results from a clinical phase II study.

Nicolay, J. (First author)DKFZ* ; Albrecht, J. D.DKFZ* ; Assaf, C. ; Dippel, E. ; Stadler, R. ; Wehkamp, U. ; Wobser, M. ; Guelow, K. ; Goerdt, S. ; Krammer, P. (Last author)DKFZ*

2021
Elsevier Amsterdam [u.a.]

This record in other databases:

Please use a persistent id in citations: doi:10.1016/S0959-8049(21)00666-3

Keyword(s): CTCL ; NFκB ; apoptosis ; clinical study ; targeted therapy

Note: #EA:A370#LA:D030#

---

Contributing Institute(s):

1. KKE Dermatoonkologie (A370)
2. Immungenetik (D030)

Research Program(s):

1. 314 - Immunologie und Krebs (POF4-314) (POF4-314)

Appears in the scientific report 2021

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 5 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---